<DOC>
	<DOCNO>NCT00774813</DOCNO>
	<brief_summary>The primary objective Phase II study demonstrate safety Nexalin Therapy investigate efficacy Nexalin Therapy .</brief_summary>
	<brief_title>Nexalin Therapy Treatment Depressive Symptoms</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , multi-center trial 3 different treatment arm . Study Tools : - Hamilton Depression Rating Scale ( HAM-D21 ) - Clinical Global Impressions ( CGI ) - Montgomery-Asberg Depression Rating Scale ( MADRS ) - Beck 's Depression Inventory - Hamilton Anxiety Rating Scale ( HAM-A ) - Hospital Anxiety Depression Scale ( HADS )</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Diagnosed mild moderate depression episode , base HAMD21 Rating Scale ( 1013 = mild ; 1417 = mild moderate ) Diagnosed mild moderate depression episode base ICD10 Diagnostic Guidelines Is willing able spend 4 week hospital inpatient Is willing able return clinic followup period A HAMD21 Rating Scale &lt; 10 &gt; 17 Diagnosed outside mild moderate depression episode range base ICD10 Diagnostic Guidelines Unable complete washout interval without take antidepressant psychotropic medication Is pregnant may pregnant Sensitivity electrode and/or conductive gel adhesives Break skin integrity area electrode placement Currently take immune suppress drug suspect use narcotic Presence implant electronic device , cardiac stimulator , pacemaker History brain injury , include seizure , epilepsy , stroke , tumor central nervous system , hydrocephalus History heart attack , congestive heart failure , uncontrolled hypertension History schizophrenia manicdepressive syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Depression</keyword>
	<keyword>Mild</keyword>
	<keyword>Moderate</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Kalaco Scientific , Inc .</keyword>
</DOC>